Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06560411 · ClinicalTrials.gov registry record · NA
Evaluation of Auto-EPAP for Management of Upper Airway Obstruction During Non-Invasive Ventilation
A NA study of Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease (COPD), sponsored by Breas Medical.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
- 4
- Study locations
NCT06560411: Completed NA study of Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease (COPD), sponsored by Breas Medical.
NCT06560411 is a NA study of Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease (COPD) that has completed, run by Breas Medical. The registered enrollment target is 23 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (90% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06560411, a NA study of Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease (COPD), has completed, sponsored by Breas Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
- 4
- Study locations
Study Summary
To evaluate the safety and effectiveness of the Automatic Expiratory Positive Airway Pressure (Auto-EPAP) feature versus manual expiratory positive airway pressure (EPAP) in the Vivo 45 LS Ventilator.
Primary Outcome
The log of the subject's mean Oxygen Desaturation Index (ODI4%) measured during each overnight polysomnography assessment (i.e., log10 (mean+1)).
Conditions Studied
Interventions
- DEVICE Non-Invasive Ventilation
Study Locations (4)
Arizona
- Insomnia and Sleep Institute of Arizona, LLC - Scottsdale
California
- University of California San Diego - San Diego
Colorado
- Delta Waves - Colorado Springs
South Carolina
- Bogan Sleep Consultants - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2024-10-03 |
| Est. Completion | 2025-08-07 |
| Phase | NA |
What the finished NCT06560411 record still lists
NCT06560411 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (90% lower).
The record links to 4 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which Non-Invasive Ventilation is the first listed.
NCT06560411 reports a single indexed study location in Arizona, California, Colorado.
Frequently Asked Questions
What is clinical trial NCT06560411 about?
NCT06560411 is a clinical study titled "Evaluation of Auto-EPAP for Management of Upper Airway Obstruction During Non-Invasive Ventilation". To evaluate the safety and effectiveness of the Automatic Expiratory Positive Airway Pressure (Auto-EPAP) feature versus manual expiratory positive airway pressure (EPAP) in the Vivo 45 LS Ventilator.
What is the current status of trial NCT06560411?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2024-10-03. Estimated completion is 2025-08-07.
What conditions does trial NCT06560411 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea, Chronic Obstructive Pulmonary Disease (COPD), Neuromuscular Diseases (NMD), Obesity Hypoventilation Syndrome (OHS).
What interventions are being tested in trial NCT06560411?
The interventions under investigation include: Non-Invasive Ventilation (DEVICE).
Who is sponsoring clinical trial NCT06560411?
This trial is sponsored by Breas Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06560411 being conducted?
This trial has 4 study locations across Arizona, California, Colorado, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06560411's enrollment target sits among peer trials
23 134th of 155 higher than 21 of 155 other Obstructive Sleep Apnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
-
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
RECRUITING · NA
-
Mandibular Advancement Device and Changes in Nocturia
RECRUITING · NA
-
Severe Label Expansion for EVO Products Trial
RECRUITING · NA
-
App-Based Optimization of Long-Term CPAP Adherence and Quality of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI